Primary Site Identification of Soft‐Tissue Mass: Things to Know in MRI Assessment

Abstract

The spectrum of soft‐tissue mass is varied, including neoplastic and nonneoplastic/inflammatory lesions. However, soft‐tissue tumors have similar imaging findings and, therefore, the diagnosis of soft‐tissue mass is challenging. Although careful assessment of the internal characteristics on imaging can often narrow the differential diagnoses, the differential diagnosis may be out of the question if identification of the soft‐tissue mass origin is missed. The purpose of this article is to review the imaging findings and the essential anatomy to identify the primary site of the soft‐tissue mass, and discuss the associated potential pitfalls. In order not to fall into a pitfall, recognition of characteristic imaging findings indicating the origin of the soft‐tissue mass and anatomical knowledge of the normal tissue distribution are necessary. Level of Evidence 5 Technical Efficacy Stage 3

Molecular Design of Magnetic Resonance Imaging Agents Binding to Amyloid Deposits

“…A number of metal-based (mainly gadolinium-based) contrast agents have been developed which increase the relaxation rate in the immediate vicinity of the metal and improve the visibility of pathologies [ 69 ]. Conventional or contrast-enhanced 1 H MRI has been successfully used to diagnose many different pathological conditions: neurological tumors [ 70 ]; issues with the structure and function of the heart [ 71 , 72 ]; joint diseases and soft tissue tumors [ 73 , 74 , 75 , 76 ]; stenosis or aneurysm of the arteries [ 77 ]; and lesions of the liver, pancreas, and bile ducts [ 78 , 79 , 80 ].…”

Assembly of Poly(vinylphosphonic acid)-Based Double Hydrophilic Block Copolymers by Gadolinium Ions for the Formation of Highly Stable MRI Contrast Agents

“…Magnetic resonance imaging (MRI) is a powerful medical imaging technique based on nuclear magnetic resonance capable of probing the morphology and health of biological tissues. − Longitudinal and transversal relaxation times (respectively, T 1 and T 2 ) as well as proton density are all factors providing contrast between tissue types, including pathological states. Endogenous molecular or nanoparticular contrast agents (CAs) are often needed to enhance or optimize MRI resolution. , The two most common classes of CAs are (a) T 1 or positive CAs that shorten proton longitudinal relaxation time and (b) T 2 or negative CAs that shorten proton transversal relaxation time.…”